See every side of every news story

Browser Extension

Monday, February 24, 2025

US Edition

Subscribe Login

Volodymyr Zelenskyy

German Politics

Israel-Hamas Conflict

Cardiac Interventions Today image

News from Cardiac Interventions Today

Topics Most Covered by Cardiac Interventions Today

Johnson & Johnson

Johnson & Johnson

Sources Covering Similar Topics

Cardiovascular News

Endovascular Today

Medical Device Network

Interventional News

cardiovascularbusiness.com

Cardiovascular News

Endovascular Today

Medical Device Network

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Pope Francis Vatican Olaf Scholz Volodymyr Zelenskyy Ukraine War

Trending in U.S.Israel-Hamas Conflict Basketball Baseball Tennis Donald Trump

Trending in U.K.Israel-Hamas Conflict Premier League Manchester City Manchester United Aston Villa

Trending Topics

Pope Francis Vatican Olaf Scholz Volodymyr Zelenskyy Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Blindspot Local

News from Cardiac Interventions Today

See all of Cardiac Interventions Today news coverage in one place. Discover how Cardiac Interventions Today’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 30 have been published by Cardiac Interventions Today which Ground News has aggregated in the past 3 months.

The Ground News media bias check for Cardiac Interventions Today is . Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Cardiac Interventions Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

See all of Cardiac Interventions Today news coverage in one place. Discover how Cardiac Interventions Today’s media bias informs their coverage and compare with thousands of other news outlets. In total, 30 have been published by Cardiac Interventions Today which Ground News has aggregated in the past 3 months.

The Ground News media bias check for Cardiac Interventions Today is . Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. Cardiac Interventions Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Cardiac Interventions Today

Where is Cardiac Interventions Today located?Cardiac Interventions Today's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Breaking News Topics Related to Cardiac Interventions Today

Maryland

California, United States

United States

Similar News Topics

hitconsultant.net

Interventional News

Endovascular Today

Cardiovascular News

cardiovascularbusiness.com

Top Cardiac Interventions Today News

Biotronik Partners With Egg Medical to Market EggNest Radiation Protection Systems - Cardiac Interventions Today

United States · United States

Biotronik Partners With Egg Medical to Market EggNest Radiation Protection Systems - Cardiac Interventions Today

February 19, 2025—Biotronik announced it is partnering with Egg Medical, Inc. to cosell Egg Medical’s EggNest radiation protection systems for health care workers in the United States. According to the company, the EggNest systems (EggNest XR, EggNest Protect, and EggNest Complete) can be used across various fluoroscopy procedure types without impacting workflow. The EggNest systems, which are commercially available in the United System, are int…See the Story

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Cardiac Interventions Today

Maryland · Maryland

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Cardiac Interventions Today

February 18, 2025—Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its next-generation clot removal technology platform for venous thromboembolism (VTE). According to the company, the funding round accelerates its VTE treatment program, with an initial focus on advancing solutions for pulmonary embolism (PE). E2 stated it seeks to address critical unmet needs in intervention…See the Story

WhiteSwell's eLym System trial indicates positive outcomes for ADHF patients

WhiteSwell's eLym System trial indicates positive outcomes for ADHF patients

WhiteSwell has reported encouraging results from its DELTA-HF trial, which evaluated the eLym System in treating individuals with ADHF.The post WhiteSwell’s eLym System trial indicates positive outcomes for ADHF patients appeared first on Medical Device Network.See the Story

CVRx Barostim Demonstrates Reduction in Health Care Use in Real-World Data - Cardiac Interventions Today

Boston, Massachusetts · Boston

CVRx Barostim Demonstrates Reduction in Health Care Use in Real-World Data - Cardiac Interventions Today

February 12, 2025—CVRx, Inc. announced new real-world evidence demonstrating that use of the company’s Barostim implant was associated with large, statistically significant reductions in health care use, including reductions in hospital visits (ie, hospitalization and emergency department visits) and length of stay after implantation. The data were presented at the recent Technology and Heart Failure Therapeutics (THT) conference in Boston, Mass…See the Story

Avertix Guardian System Evaluated for Cost-Effectiveness in ACS Patients - Cardiac Interventions Today

Durham, North Carolina · Durham

Avertix Guardian System Evaluated for Cost-Effectiveness in ACS Patients - Cardiac Interventions Today

February 18, 2025—Avertix Medical, Inc. recently announced new data confirming the cost-effectiveness of the company’s Guardian system in high-risk acute coronary syndrome (ACS) patients. The Guardian system is a real-time, continuous heart attack detection and patient alerting system. The analysis leveraged data from the pivotal ALERTS clinical trial and was complemented by findings from relevant literature, noted Avertix. According to the comp…See the Story

Vantis Vascular completes first commercial use of CrossFAST system

Vantis Vascular completes first commercial use of CrossFAST system

Vantis Vascular has completed the first commercial application of its CrossFAST Integrated Microcatheter Advanced Delivery System.The post Vantis Vascular completes first commercial use of CrossFAST system appeared first on Medical Device Network.See the Story

Advanced Bifurcation Systems Secures Financing for Technology Development - Cardiac Interventions Today

Maryland · Maryland

Advanced Bifurcation Systems Secures Financing for Technology Development - Cardiac Interventions Today

January 22, 2025—Advanced Bifurcation Systems Inc. (ABS), a developer of solutions for bifurcation lesions in coronary angioplasty, recently announced the closure of a $20.8 million Simple Agreement for Future Equity (SAFE) financing round. As previously announced, ABS is developing a stent delivery system designed to treat all coronary bifurcation lesions in coronary angioplasties. This SAFE financing builds on receipt of FDA Breakthrough Devic…See the Story

CoreMedic Partners With InnoRa for Development of ChordArt TMVr Device - Cardiac Interventions Today

Maryland · Maryland

CoreMedic Partners With InnoRa for Development of ChordArt TMVr Device - Cardiac Interventions Today

January 17, 2025—CoreMedic GmbH recently announced it has entered into a strategic partnership with InnoRa GmbH to accelerate the clinical development of its ChordArt transcatheter mitral valve repair (TMVr) device. According to the company, the ChordArt TMVr system is designed to improve chorda repair procedures across all crucial parameters. These parameters include reduction of patient trauma, duration of procedure, complexity, operator depen…See the Story

Biotronik nets short DAPT and calcified lesion indications for Orsiro Mission DES - Cardiovascular News

Germany · Germany

Biotronik nets short DAPT and calcified lesion indications for Orsiro Mission DES - Cardiovascular News

Biotronik has announced CE mark approval of two new indications for the Orsiro Mission drug-eluting stent (DES). These include one-month dual antiplatelet therapy (DAPT) for high bleeding risk (HBR) patients, allowing practitioners to offer personalised, shorter DAPT durations to their patients at high risk of bleeding events, in accordance with the most recent guidelines. Additionally, the Orsiro Mission DES has been approved for calcified lesi…See the Story

Medtronic inks distribution deal with Contego with option to buy firm

Health · United States

Medtronic inks distribution deal with Contego with option to buy firm

100% Center coverage: 1 sources

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and thrombectomy devices.See the Story

Corvia Atrial Shunt Receives CE Mark Certification Under EU MDR - Cardiac Interventions Today

European Union · Menlo Park

Corvia Atrial Shunt Receives CE Mark Certification Under EU MDR - Cardiac Interventions Today

January 10, 2025—Corvia Medical, Inc. recently announced that it has achieved CE Mark certification for the Corvia atrial shunt system under the European Union Medical Device Regulations—EU MDR 2017/745. The company stated that the device is a catheter-based cardiac implant designed to reduce heart failure (HF) symptoms by lowering pressures in the heart and lungs. According to the company, the Corvia atrial shunt is designed to alleviate elevat…See the Story